Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety

Journal of Medicinal Chemistry

Volumn 42, Issue 20, 1999, Pages 4185-4192

  Amblard, Muriel ^a   Daffix, Isabelle ^a   Bedos, Philippe ^a   Bergé, Gilbert ^a   Pruneau, Didier ^b   Paquet, Jean Luc ^b   Luccarini, Jean Michel ^b   Bélichard, Pierre ^b   Dodey, Pierre ^b   Martinez, Jean ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b Laboratoires Fournier SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR AGONIST; ICATIBANT;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; DRUG CONFORMATION; SYNTHESIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DRUG DESIGN; FEMALE; HUMANS; INOSITOL PHOSPHATES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TRANSFECTION; UMBILICAL CORD; UTERINE CONTRACTION;

EID: 0033533863     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9901529     Document Type: Article

References (38)

1. Hess, J. F.; Borkowski, J. A.; Young, G. S.; Strader, C. D.; Ransom, R. W. Cloning and Pharmacological characterization of the human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 1992, 184, 260-268.
2. Menke, J. G.; Borkowski, J. A.; Bierilo, K. K.; MacNeil, T.; Derrick, A. W.; Schneck, K. A.; Ransom, R. W.; Strader, C. D.; Linemeyer, D. L.; Hess, J. F. Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 1994, 269, 21583-21586.
3. Regoli, D.; Barabe, J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 1980, 32, 1-46.
4. Bhoola, K. D.; Figueroa, C. D.; Worthy, K. Bioregulation of kinins: kallikrein, kininogen, and related kininases. Pharmacol. Rev. 1992, 44, 1-78.
5. Dray, A.; Perkins, M. Bradykinin and inflammatory pain. Trends Neurosci. 1993, 16, 99-104.
6. (a)Steranka, L. R.; Manning, D. C.; de Haas, C. J.; Ferkany, J. W.; Borosky, S. A.; Connor, J. R.; Vavrek, R. J.; Stewart, J. M.; Snyder, S. H. Bradykinin as pain mediator: receptors are localized to sensory neurons and antagonists have analgesic effects. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 3245-3249.
7. (b) Stewart, J. M. The kinin system in inflammation. Agents Actions 1993, 42S, 145-147.
8. Stewart, J. M.; Gera, L.; Chan, D. C.; Whalley, E. T.; Hanson, W. L.; Zuzack, J. S. Potent, long-acting, orally active bradykinin antagonists for a wide range of applications. Immunopharmacology 1997, 36, 167-172.
9. Regoli, D.; Allogho, S. N.; Rizzi, A.; Gobeil, F. J. Bradykinin receptors and their antagonists. Eur. J. Pharmacol. 1998, 348, 1-10.
10. Lembeck, F.; Griesbacher, T.; Eckhardt, M.; Henke, St.; Breipohl, G.; Knolle, J. New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol. 1991, 102, 297-304.
11. Bao, G.; Gohlke, P.; Unger, T. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J. Cardiovasc. Pharmacol. 1992, 20, S96-S99.
12. Martorana, P. A.; Kettenbach, B.; Breipol, G.; Linz, W.; Scholkens, B. A. Reduction of infarct by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur. J. Pharmacol. 1990, 182, 395-396.
13. McDonald, K. M.; Mock, J.; D'Ajoia, M.; Parrish, T.; Hauer, K.; Francis, G.; Stillman, A.; Cohn, J. N. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation 1995, 91, 2043-2048.
14. Inamura, T.; Nomura, R.; Black, K. L. Intracarotid infusion of RMP-7, a method for selective drug delivery to brain tumors. J. Neurosurg. 1994, 81, 752-758.
15. Ford, J.; Osborn, C.; Barton, T.; Bleehen, N. M. A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma. Eur. J. Cancer 1998, 34, 1807-1811.
16. LeMay, D. R.; Kittaka, M.; Gordon, E. M.; Gray, B.; Stins, M. F.; McComb, J. G.; Jovanovic, S.; Tabrizi, P.; Weiss, M. H.; Bartus, R.; Anderson, W. F.; Zlokovic, B. V. Intravenous RMP-7 increases delivery of Ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. Hum. Gene Ther. 1998, 9, 989-995.
17. Elliot, P. J.; Mackic, J. B.; Graney, W. F.; Bartus, R. T.; Zlokovic, B. V. RMP-7, a bradykinin agonist. Increases permeability of blood-ocular barriers in the guinea pig. Invest. Ophthalmol. Vis. Sci. 1995, 36, 2542-2547.
18. Elliot, P. J.; Bartus, R. T.; Mackic, J. B.; Zlokovic, B. V. Intravenous infusion of RMP-7 increases ocular uptake of ganciclovir. Pharm. Res. 1997, 14, 80-85.
19. Cann, J. R.; London, R. E.; Matwiyoff, N. A.; Stewart, J. M. A combined spectroscopic study of the solution conformation of bradykinin. Adv. Exp. Med. Biol. 1983, 156A, 495-500.
20. Lee, S. C.; Russel, A. F.; Laidig, W. D. Three dimensional structure of bradykinin in SDS micelles. Int. J. Pept. Protein Res. 1990, 35, 367-377.
21. Kyle, D. J.; Martin, J. A.; Farmer, S. G.; Burch, R. M. Design and conformational analysis of several highly potent bradykinin receptor antagonists. J. Med. Chem. 1991, 34, 1230-1233.
22. Kyle, D. J.; Martin, J. A.; Burch, R. M.; Carter, J. P.; Lu, S.; Meeker, S.; Prosser, J. C.; Sullivan, J. P.; Togo, J.; Noronha-Blob, L.; Sinsko, J. A.; Walters, R. F.; Whaley, L. W.; Hiner, R. N. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides. J. Med. Chem. 1991, 34, 2649-2653.
23. Kyle, D. J.; Blake, P. R.; Smithwick, D.; Green, L. M.; Martin, J. A.; Sinsko, J. A.; Summers, M. F. NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal β-turns. J. Med. Chem. 1993, 36, 1450-1460.
24. Dorer, F. E.; Ryan, J. W.; Steward, J. M. Hydrolysis of brady-kinin and it's higher homologues by angiotensin-converting enzyme. Biochem. J. 1974, 14, 915-917.
25. For reviews see: (a) Olson, G. L.; Bolin, D. R.; Bonner, M. P.; Bös, M.; Cook, C. M.; Fry D. C.; Graves, B. J.; Hatada, M.; Hill, D. E.; Kahn, M.; Madison, V. S.; Rusiecki, V. K.; Sarabu, R.; Sepinwall, J.; Vincent, G. P.; Voss, M. E. Concepts and progress in the development of peptide mimetics. J. Med. Chem. 1993, 36, 3039-3049.
26. (b) Fairlie, D. P.; Abbenante, G.; March, D. R. Macrocyclic peptidomimetics - Forcing peptides into bioactive conformations. Curr. Med. Chem. 1995, 2, 654-686.
27. Rich, D. H. Peptidase inhibitors. In Comprehensive medicinal chemistry: The rational design, mechanistic study and therapeutic application of chemical compounds; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: New York, 1990; pp 391-44 and references therein.
28. Freidinger, R. M.; Veber, D. F.; Perlow, D. S.; Brooks, J. R.; Saperstein, R. Bioactive conformation of Luteinizing Hormone-Releasing Hormone: evidence from a conformationally constrained analogue. Science 1980, 210, 656-658.
29. Mavunkel, B. J.; Lu, Z.; Goehring, R. R.; Lu, S.; Chakravarty, S.; Perumattam, J.; Novotny, E. A.; Connolly, M.; Valentine, H.; Kyle, D. J. Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system. J. Med. Chem. 1996, 39, 3169-3173.
30. Slade, J.; Stanton, J. L.; Ben-David, D.; Mazzenga, G. C. Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives. J. Med. Chem. 1985, 25, 1517-1521.
31. Barany, G.; Merrifield, R. B. Solid-phase peptide synthesis. In The Pepides, Analysis, Synthesis and Biology; Gross, E., Meienhofer, J., Eds.; Academic Press: New York, 1979; pp 3-284.
32. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Peptide coupling reagents. N-[oxytris(dimethylamino)phosphoniumbenzotriazole hexafluorophosphate. Tetrahedron Lett. 1975, 1219-1222.
33. 2 receptor: interspecies variability and dissociation between binding and functional responses. Br. J. Pharmacol. 1999, 126, 1083-1090.
34. Bastian, S.; Loillier, B.; Paquet, J. L.; Pruneau, D. Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization. Br. J. Pharmacol. 1997, 122, 393-399.
35. Gisin, B. F. The preparation of Merrifield-resins through total esterification with cesium salts. Helv. Chim. Acta 1973, 56, 1476-1482.
36. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34, 595-598.
37. 3CN); gradient 0-100% B in 50 min.
38. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 721, 248-254.